Uploaded image for project: 'IGB'
  1. IGB
  2. IGBF-3083

Revise paper as per Editor comments

    Details

    • Type: Task
    • Status: Closed (View Workflow)
    • Priority: Major
    • Resolution: Done
    • Affects Version/s: None
    • Fix Version/s: None
    • Labels:
      None

      Description

      Revise Frontiers in Bioinformatics manuscript as requested by Editor.

      This is due by Friday Feb 25 at the latest.

      Latest draft is: 2022-02-01-BiovizConnect.docx, in Dropbox / IGB / Manuscripts / biovizConnect / Frontiers

      Editor's comments:

      Thanks for addressing all reviewers concerns in the previous round. Whilst the manuscript is close to acceptance I noticed some minor issues:

      R1. in 497-514 you outline a 'subtle' issue concerning indexed file formats like BAM. This paragraph, whilst informative, id not explain exactly what the subtle is.. for instance: as currently written, the undesirable aspect of the physician use case is not actually explained. I'm guessing the issue is that the 'whole genome' is exposed to the user who is only interested in a specific region ? If that is indeed the case, then I recommend mentioning the 'BEACONS' network (https://beacon-project.io/) which aims to allow secure dissemination of such personal genomic data without full disclosure (and it is conceivable, a beacon api instance could be spun up for a cyverse result .. ).

      R2. Please provide a URL for the UCSC JSON interface

      R3. Recommend that FIgure 2 could be omitted. Instead line 200-203 should refer to the menu shown in Figure 3 (which will become Figure 2 should you agree with this recommendation).

      R4. Minor Typos/Grammar:
      line 424: "we considered user several" .. sugg. 'user' should be omitted

      line 454-454: "However, since we first released BioViz Connect, the CyVerse development team have improved data throughput, making this design less problematic." - do you mean to say "those tools' design" ?

      Line 468: I bashfully request you use the more modern "Jalview" rather than 'JalView', but greatly appreciate your citation of my work.

      Line 489: "The first technical limitation has to do with how data flow from the CyVerse back end data store.." - sugg. 'flows'

      Letter from Editor requests continue to track changes:

      Dear Dr Loraine,

      I'm contacting you to request your action on the manuscript "BioViz Connect: Web application linking CyVerse cloud resources to genomic visualization in the Integrated Genome Browser" submitted to Frontiers in Bioinformatics, section Data Visualization.

      Please access the review forum using the link below to respond to the comments in the Editor's tab and resubmit the revised manuscript if necessary by 25 Feb 2022. We encourage you to submit your revised manuscript with tracked changes to facilitate the review.

      http://review.frontiersin.org/review/764619/0/0

      The review process is almost complete and we look forward to receiving your response in time. Should you require more time please do not hesitate to contact the editorial office.

      With best regards,

      Jim Procter
      Guest Associate Editor, Frontiers in Bioinformatics
      https://www.frontiersin.org/

        Attachments

          Activity

          ann.loraine Ann Loraine created issue -
          ann.loraine Ann Loraine made changes -
          Field Original Value New Value
          Epic Link IGBF-2376 [ 18533 ]
          ann.loraine Ann Loraine made changes -
          Rank Ranked higher
          ann.loraine Ann Loraine made changes -
          Description Revise Frontiers in Bioinformatics manuscript as requested by Editor.

          This is due by Friday Feb 25 at the latest.

          Editor's comments:

          {quote}
          Thanks for addressing all reviewers concerns in the previous round. Whilst the manuscript is close to acceptance I noticed some minor issues:

          R1. in 497-514 you outline a 'subtle' issue concerning indexed file formats like BAM. This paragraph, whilst informative, id not explain exactly what the subtle is.. for instance: as currently written, the undesirable aspect of the physician use case is not actually explained. I'm guessing the issue is that the 'whole genome' is exposed to the user who is only interested in a specific region ? If that is indeed the case, then I recommend mentioning the 'BEACONS' network (https://beacon-project.io/) which aims to allow secure dissemination of such personal genomic data without full disclosure (and it is conceivable, a beacon api instance could be spun up for a cyverse result .. ).

          R2. Please provide a URL for the UCSC JSON interface

          R3. Recommend that FIgure 2 could be omitted. Instead line 200-203 should refer to the menu shown in Figure 3 (which will become Figure 2 should you agree with this recommendation).

          R4. Minor Typos/Grammar:
          line 424: "we considered user several" .. sugg. 'user' should be omitted

          line 454-454: "However, since we first released BioViz Connect, the CyVerse development team have improved data throughput, making this design less problematic." - do you mean to say "those tools' design" ?

          Line 468: I bashfully request you use the more modern "Jalview" rather than 'JalView', but greatly appreciate your citation of my work.

          Line 489: "The first technical limitation has to do with how data flow from the CyVerse back end data store.." - sugg. 'flows'
          {quote}
          Revise Frontiers in Bioinformatics manuscript as requested by Editor.

          This is due by Friday Feb 25 at the latest.

          Latest draft is: 2022-02-01-BiovizConnect.docx, in Dropbox / IGB / Manuscripts / biovizConnect / Frontiers

          Editor's comments:

          {quote}
          Thanks for addressing all reviewers concerns in the previous round. Whilst the manuscript is close to acceptance I noticed some minor issues:

          R1. in 497-514 you outline a 'subtle' issue concerning indexed file formats like BAM. This paragraph, whilst informative, id not explain exactly what the subtle is.. for instance: as currently written, the undesirable aspect of the physician use case is not actually explained. I'm guessing the issue is that the 'whole genome' is exposed to the user who is only interested in a specific region ? If that is indeed the case, then I recommend mentioning the 'BEACONS' network (https://beacon-project.io/) which aims to allow secure dissemination of such personal genomic data without full disclosure (and it is conceivable, a beacon api instance could be spun up for a cyverse result .. ).

          R2. Please provide a URL for the UCSC JSON interface

          R3. Recommend that FIgure 2 could be omitted. Instead line 200-203 should refer to the menu shown in Figure 3 (which will become Figure 2 should you agree with this recommendation).

          R4. Minor Typos/Grammar:
          line 424: "we considered user several" .. sugg. 'user' should be omitted

          line 454-454: "However, since we first released BioViz Connect, the CyVerse development team have improved data throughput, making this design less problematic." - do you mean to say "those tools' design" ?

          Line 468: I bashfully request you use the more modern "Jalview" rather than 'JalView', but greatly appreciate your citation of my work.

          Line 489: "The first technical limitation has to do with how data flow from the CyVerse back end data store.." - sugg. 'flows'
          {quote}
          ann.loraine Ann Loraine made changes -
          Description Revise Frontiers in Bioinformatics manuscript as requested by Editor.

          This is due by Friday Feb 25 at the latest.

          Latest draft is: 2022-02-01-BiovizConnect.docx, in Dropbox / IGB / Manuscripts / biovizConnect / Frontiers

          Editor's comments:

          {quote}
          Thanks for addressing all reviewers concerns in the previous round. Whilst the manuscript is close to acceptance I noticed some minor issues:

          R1. in 497-514 you outline a 'subtle' issue concerning indexed file formats like BAM. This paragraph, whilst informative, id not explain exactly what the subtle is.. for instance: as currently written, the undesirable aspect of the physician use case is not actually explained. I'm guessing the issue is that the 'whole genome' is exposed to the user who is only interested in a specific region ? If that is indeed the case, then I recommend mentioning the 'BEACONS' network (https://beacon-project.io/) which aims to allow secure dissemination of such personal genomic data without full disclosure (and it is conceivable, a beacon api instance could be spun up for a cyverse result .. ).

          R2. Please provide a URL for the UCSC JSON interface

          R3. Recommend that FIgure 2 could be omitted. Instead line 200-203 should refer to the menu shown in Figure 3 (which will become Figure 2 should you agree with this recommendation).

          R4. Minor Typos/Grammar:
          line 424: "we considered user several" .. sugg. 'user' should be omitted

          line 454-454: "However, since we first released BioViz Connect, the CyVerse development team have improved data throughput, making this design less problematic." - do you mean to say "those tools' design" ?

          Line 468: I bashfully request you use the more modern "Jalview" rather than 'JalView', but greatly appreciate your citation of my work.

          Line 489: "The first technical limitation has to do with how data flow from the CyVerse back end data store.." - sugg. 'flows'
          {quote}
          Revise Frontiers in Bioinformatics manuscript as requested by Editor.

          This is due by Friday Feb 25 at the latest.

          Latest draft is: 2022-02-01-BiovizConnect.docx, in Dropbox / IGB / Manuscripts / biovizConnect / Frontiers

          Editor's comments:

          {quote}
          Thanks for addressing all reviewers concerns in the previous round. Whilst the manuscript is close to acceptance I noticed some minor issues:

          R1. in 497-514 you outline a 'subtle' issue concerning indexed file formats like BAM. This paragraph, whilst informative, id not explain exactly what the subtle is.. for instance: as currently written, the undesirable aspect of the physician use case is not actually explained. I'm guessing the issue is that the 'whole genome' is exposed to the user who is only interested in a specific region ? If that is indeed the case, then I recommend mentioning the 'BEACONS' network (https://beacon-project.io/) which aims to allow secure dissemination of such personal genomic data without full disclosure (and it is conceivable, a beacon api instance could be spun up for a cyverse result .. ).

          R2. Please provide a URL for the UCSC JSON interface

          R3. Recommend that FIgure 2 could be omitted. Instead line 200-203 should refer to the menu shown in Figure 3 (which will become Figure 2 should you agree with this recommendation).

          R4. Minor Typos/Grammar:
          line 424: "we considered user several" .. sugg. 'user' should be omitted

          line 454-454: "However, since we first released BioViz Connect, the CyVerse development team have improved data throughput, making this design less problematic." - do you mean to say "those tools' design" ?

          Line 468: I bashfully request you use the more modern "Jalview" rather than 'JalView', but greatly appreciate your citation of my work.

          Line 489: "The first technical limitation has to do with how data flow from the CyVerse back end data store.." - sugg. 'flows'
          {quote}

          Letter from Editor requests continue to track changes:

          {quote}
          Dear Dr Loraine,

          I'm contacting you to request your action on the manuscript "BioViz Connect: Web application linking CyVerse cloud resources to genomic visualization in the Integrated Genome Browser" submitted to Frontiers in Bioinformatics, section Data Visualization.

          Please access the review forum using the link below to respond to the comments in the Editor's tab and resubmit the revised manuscript if necessary by 25 Feb 2022. We encourage you to submit your revised manuscript with tracked changes to facilitate the review.

          http://review.frontiersin.org/review/764619/0/0

          The review process is almost complete and we look forward to receiving your response in time. Should you require more time please do not hesitate to contact the editorial office.

          With best regards,

          Jim Procter
          Guest Associate Editor, Frontiers in Bioinformatics
          https://www.frontiersin.org/
          {quote}
          ann.loraine Ann Loraine made changes -
          Assignee Nowlan Freese [ nfreese ]
          nfreese Nowlan Freese made changes -
          Status To-Do [ 10305 ] In Progress [ 3 ]
          nfreese Nowlan Freese made changes -
          Status In Progress [ 3 ] To-Do [ 10305 ]
          ann.loraine Ann Loraine made changes -
          Comment [ I have time right now to work on merging Figure 2 and 3 now. Please let me know [~nfreese] if you are already doing this and I will wait. ]
          nfreese Nowlan Freese made changes -
          Assignee Nowlan Freese [ nfreese ] Ann Loraine [ aloraine ]
          nfreese Nowlan Freese made changes -
          Status To-Do [ 10305 ] In Progress [ 3 ]
          nfreese Nowlan Freese made changes -
          Status In Progress [ 3 ] Needs 1st Level Review [ 10005 ]
          ann.loraine Ann Loraine made changes -
          Sprint Spring 4 2022 Feb 14 - Feb 25 [ 139 ] Spring 4 2022 Feb 14 - Feb 25, Spring 5 2022 Feb 28 - Mar 11 [ 139, 140 ]
          ann.loraine Ann Loraine made changes -
          Rank Ranked higher
          ann.loraine Ann Loraine made changes -
          Status Needs 1st Level Review [ 10005 ] First Level Review in Progress [ 10301 ]
          ann.loraine Ann Loraine made changes -
          Comment [ I also made a few small changes to Figure 1. The single-headed arrow linking the box labeled "Model" and the box labeled "Database for CyVerse App invocation" should be a double-headed arrow instead. I'm not sure it's better than the currently uploaded version.
          ]
          ann.loraine Ann Loraine made changes -
          Status First Level Review in Progress [ 10301 ] Ready for Pull Request [ 10304 ]
          ann.loraine Ann Loraine made changes -
          Status Ready for Pull Request [ 10304 ] Pull Request Submitted [ 10101 ]
          ann.loraine Ann Loraine made changes -
          Status Pull Request Submitted [ 10101 ] Reviewing Pull Request [ 10303 ]
          ann.loraine Ann Loraine made changes -
          Status Reviewing Pull Request [ 10303 ] Merged Needs Testing [ 10002 ]
          ann.loraine Ann Loraine made changes -
          Status Merged Needs Testing [ 10002 ] Post-merge Testing In Progress [ 10003 ]
          ann.loraine Ann Loraine made changes -
          Resolution Done [ 10000 ]
          Status Post-merge Testing In Progress [ 10003 ] Closed [ 6 ]
          ann.loraine Ann Loraine made changes -
          Assignee Ann Loraine [ aloraine ] Nowlan Freese [ nfreese ]
          nfreese Nowlan Freese made changes -
          Link This issue relates to IGBF-3112 [ IGBF-3112 ]

            People

            • Assignee:
              nfreese Nowlan Freese
              Reporter:
              ann.loraine Ann Loraine
            • Votes:
              0 Vote for this issue
              Watchers:
              2 Start watching this issue

              Dates

              • Created:
                Updated:
                Resolved: